celecoxib has been researched along with fluorobenzenes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gori, T; Liuni, A; Luca, MC; Parker, JD | 2 |
2 trial(s) available for celecoxib and fluorobenzenes
Article | Year |
---|---|
Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
Topics: Adolescent; Adult; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Endothelium, Vascular; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Preconditioning, Myocardial; Male; Models, Cardiovascular; Myocardial Reperfusion Injury; Premedication; Pyrazoles; Pyrimidines; Radial Artery; Rosuvastatin Calcium; Sulfonamides; Vasodilation; Young Adult | 2010 |
Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.
Topics: Adolescent; Adult; Analysis of Variance; Blood Flow Velocity; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Administration Schedule; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Ischemia; Male; Ontario; Pyrazoles; Pyrimidines; Radial Artery; Regional Blood Flow; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Time Factors; Vasodilation; Young Adult | 2012 |